Cortisol Levels During First Admission Day Are Associated With Clinical Outcomes in Surgical Critically Ill Patients.
Journal
Critical care explorations
ISSN: 2639-8028
Titre abrégé: Crit Care Explor
Pays: United States
ID NLM: 101746347
Informations de publication
Date de publication:
01 May 2024
01 May 2024
Historique:
medline:
9
5
2024
pubmed:
9
5
2024
entrez:
9
5
2024
Statut:
epublish
Résumé
To explore the correlation between cortisol levels during first admission day and clinical outcomes. Although most patients exhibit a surge in cortisol levels in response to stress, some suffer from critical illness-related corticosteroid insufficiency (CIRCI). Literature remains inconclusive as to which of these patients are at greater risk of poor outcomes. A retrospective study. A surgical ICU (SICU) in a tertiary medical center. Critically ill patients admitted to the SICU who were not treated with steroids. Levels of cortisol taken within 24 hours of admission (day 1 [D1] cortisol) in 1412 eligible patients were collected and analyzed. Results were categorized into four groups: low (0-10 µg/dL), normal (10-25 µg/dL), high (25-50 µg/dL), and very high (above 50 µg/dL) cortisol levels. Primary endpoint was 90-day mortality. Secondary endpoints were the need for organ support (use of vasopressors and mechanical ventilation [MV]), ICU length of stay (LOS), and duration of MV. The majority of patients (63%) had high or very high D1 cortisol levels, whereas 7.6% had low levels and thus could be diagnosed with CIRCI. There were statistically significant differences in 90-day mortality between the four groups and very high levels were found to be an independent risk factor for mortality, primarily in patients with Sequential Organ Failure Assessment (SOFA) less than or equal to 3 or SOFA greater than or equal to 7. Higher cortisol levels were associated with all secondary endpoints. CIRCI was associated with favorable outcomes. In critically ill surgical patients D1 cortisol levels above 50 mcg/dL were associated with mortality, need for organ support, longer ICU LOS, and duration of MV, whereas low levels correlated with good clinical outcomes even though untreated. D1 cortisol level greater than 50 mcg/dL can help discriminate nonsurvivors from survivors when SOFA less than or equal to 3 or SOFA greater than or equal to 7.
Identifiants
pubmed: 38722303
doi: 10.1097/CCE.0000000000001086
pii: 02107256-202405000-00007
doi:
Substances chimiques
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1086Informations de copyright
Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.
Déclaration de conflit d'intérêts
The authors have disclosed that they do not have any potential conflicts of interest.
Références
Injury. 2021 Sep;52(9):2522-2525
pubmed: 34158159
Am Surg. 2014 Nov;80(11):1112-8
pubmed: 25347501
Nat Rev Endocrinol. 2019 Jul;15(7):417-427
pubmed: 30850749
Crit Care Med. 2021 Nov 1;49(11):e1063-e1143
pubmed: 34605781
J Intensive Care Med. 2012 Feb;27(1):37-44
pubmed: 21257631
Sci Rep. 2019 Apr 12;9(1):6008
pubmed: 30979928
Br J Anaesth. 2000 Jul;85(1):109-17
pubmed: 10927999
Trauma Surg Acute Care Open. 2020 Jan 19;5(1):e000386
pubmed: 32072017
Crit Care Med. 2008 Jun;36(6):1937-49
pubmed: 18496365
J Trauma Acute Care Surg. 2014 Jun;76(6):1390-6
pubmed: 24854306
JAMA Netw Open. 2022 Jun 1;5(6):e2217812
pubmed: 35731516
N Engl J Med. 2013 Apr 18;368(16):1477-88
pubmed: 23506003
Scand J Trauma Resusc Emerg Med. 2013 Apr 20;21:33
pubmed: 23601250
N Engl J Med. 2008 Jan 10;358(2):111-24
pubmed: 18184957
Intensive Care Med. 2017 Dec;43(12):1751-1763
pubmed: 28940011
Ann Intensive Care. 2021 Apr 26;11(1):65
pubmed: 33900478
Anesthesiology. 1984 Dec;61(6):647-51
pubmed: 6095700
J Trauma. 2008 Sep;65(3):573-9
pubmed: 18784570
Endocr Rev. 1984 Winter;5(1):25-44
pubmed: 6368214
Chest. 2008 Nov;134(5):947-954
pubmed: 18753464
Neuroimmunomodulation. 2015;22(1-2):6-19
pubmed: 25227402
Clin Endocrinol (Oxf). 2018 Nov;89(5):554-567
pubmed: 30047158
Crit Care. 2006;10(6):176
pubmed: 17147770
Eur Respir J. 2010 Sep;36(3):615-21
pubmed: 20110392
Crit Care. 2006;10(5):R149
pubmed: 17062164
J ASEAN Fed Endocr Soc. 2023;38(1):90-99
pubmed: 37252409
Intensive Care Med. 2011 Jun;37(6):901-10
pubmed: 21373823
Am Surg. 2011 May;77(5):579-85
pubmed: 21679591
J Clin Endocrinol Metab. 2022 Jun 16;107(7):2057-2064
pubmed: 35358303
Crit Care. 2010;14(6):R238
pubmed: 21192800
N Engl J Med. 2018 Mar 01;378(9):809-818
pubmed: 29490185
JAMA. 2002 Aug 21;288(7):862-71
pubmed: 12186604
Br J Anaesth. 2004 Sep;93(3):393-9
pubmed: 15220171
Lancet. 1991 Mar 9;337(8741):582-3
pubmed: 1671944
Chest. 2005 Mar;127(3):1031-8
pubmed: 15764790
Intensive Care Med. 2009 Dec;35(12):2151-6
pubmed: 19760208
Anesthesiology. 2017 Jul;127(1):166-172
pubmed: 28452806
Intensive Care Med. 2005 Mar;31(3):325-6
pubmed: 15750800
J Clin Endocrinol Metab. 2016 Feb;101(2):364-89
pubmed: 26760044
N Engl J Med. 1997 Oct 30;337(18):1285-92
pubmed: 9345079